Problem statement: Answer the MCQ question.
Question: Which drug exhibits a 17.720% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a: N#C/C(N=Nc1ccccc1O)=N\Nc1ccccc1O
b: COc1ccccc1CNC(=O)CCCNS(=O)(=O)c1cccc2nsnc12
c: CCCc1nn(C)c(C(=O)Nc2ccc(C(C)(C)C)cc2)c1Cl
Answer: c. CCCc1nn(C)c(C(=O)Nc2ccc(C(C)(C)C)cc2)c1Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCc1nn(C)c(C(=O)Nc2ccc(C(C)(C)C)cc2)c1Cl
CCCc1nn(C)c(C(=O)Nc2ccc(C(C)(C)C)cc2)c1Cl
N-(4-tert-butylphenyl)-4-chloro-2-methyl-5-propylpyrazole-3-carboxamide